| |
 |
|
Class Information
Number: 514/279
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos
Description: Subject matter wherein the six-membered hetero ring is one of the cyclos of a polycyclo ring system.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6893668 |
Process for isolation of anticancer agent camptothecin from Nothapodytes foetida |
May. 17, 2005 |
| 6887882 |
Pharmaceutical compositions comprising chelidonine or derivatives thereof |
May. 3, 2005 |
| 6878737 |
Reversal of multidrug resistance in human colon carcinoma cells |
Apr. 12, 2005 |
| 6875439 |
Formulation containing amphipathic weak base and/or amphipathic cation and multiple drug resistance inhibitor |
Apr. 5, 2005 |
| 6872746 |
Isomeric fused pyrrolocarbazoles and isoindolones |
Mar. 29, 2005 |
| 6864276 |
Active substance combinations having insecticidal and acaricidal properties |
Mar. 8, 2005 |
| 6844353 |
Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens |
Jan. 18, 2005 |
| 6828327 |
Macroheterocylic compounds useful as kinase inhibitors |
Dec. 7, 2004 |
| 6825206 |
Camptothecin compounds with a thioether group |
Nov. 30, 2004 |
| 6815438 |
Heteroaryl-diazabicycloalkanes |
Nov. 9, 2004 |
| 6809103 |
Camptothecin analogs and methods of preparation thereof |
Oct. 26, 2004 |
| 6806291 |
Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
Oct. 19, 2004 |
| 6790847 |
Topical application of cetirizine and loratadine |
Sep. 14, 2004 |
| 6784186 |
Therapeutic compounds |
Aug. 31, 2004 |
| 6770654 |
Indole derivatives and use thereof in medicines |
Aug. 3, 2004 |
| 6767888 |
Neuroprotective methods and reagents |
Jul. 27, 2004 |
| 6703398 |
Orally administered analgesic compositions containing nalbuphine |
Mar. 9, 2004 |
| 6696480 |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization |
Feb. 24, 2004 |
| 6689788 |
Method and composition for treatment of inflammatory bowel disease |
Feb. 10, 2004 |
| 6686347 |
Phthalazine derivatives for treating inflammatory diseases |
Feb. 3, 2004 |
| 6667304 |
Polycyclic azaindole compounds |
Dec. 23, 2003 |
| 6642248 |
Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
Nov. 4, 2003 |
| 6638941 |
Conformationallly constrained peptidomimetics as .beta.-turn templates and modulators of SH3 domains |
Oct. 28, 2003 |
| 6623930 |
Inhibition of human telomerase by a G-quadruplex-interaction compound |
Sep. 23, 2003 |
| 6613313 |
Aniline compound-containing hair dye composition and method of dyeing hair |
Sep. 2, 2003 |
| 6608063 |
Pyrazine based inhibitors of glycogen synthase kinase 3 |
Aug. 19, 2003 |
| 6608073 |
Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
Aug. 19, 2003 |
| 6602896 |
p38MAPK inhibitor and uses thereof |
Aug. 5, 2003 |
| 6534514 |
Kappa opioid receptor antagonists |
Mar. 18, 2003 |
| 6528517 |
Synthesis of quinobenzoxazine analogues with topoisomerase II and quadruplex interactions for use as antineoplastic agents |
Mar. 4, 2003 |
| 6528518 |
Treatment of depression with kappa receptor antagonists |
Mar. 4, 2003 |
| 6514516 |
Formulations and methods for providing prolonged local anesthesia |
Feb. 4, 2003 |
| 6503919 |
Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin carboxylate |
Jan. 7, 2003 |
| 6500824 |
Kappa (OP2) opioid receptor antagonists |
Dec. 31, 2002 |
| 6465479 |
Pyridomorphinans and use thereof |
Oct. 15, 2002 |
| 6423751 |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization |
Jul. 23, 2002 |
| 6410041 |
Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine |
Jun. 25, 2002 |
| 6407115 |
Hexa-cyclic compound |
Jun. 18, 2002 |
| 6407089 |
Triazatrinaphthyrins and the use thereof |
Jun. 18, 2002 |
| 6383528 |
Pharmaceutical composition comprising ticlopidine and Ginkgo biloba extract |
May. 7, 2002 |
| 6365594 |
Heterocycle-condensed morphinoid derivatives (II) |
Apr. 2, 2002 |
| 6350756 |
Camptothecin derivatives |
Feb. 26, 2002 |
| 6323038 |
Diagnostic reagent for complications associated with diabetes or renal failure |
Nov. 27, 2001 |
| 6306849 |
Selected derivatives of K-252a |
Oct. 23, 2001 |
| 6291470 |
Indole derivatives process for producing the same and medicinal uses of the same |
Sep. 18, 2001 |
| 6288074 |
Method of treating lymphoproliferative syndrome |
Sep. 11, 2001 |
| 6288073 |
Acronycine derivatives, preparation method and pharmaceutical compositions |
Sep. 11, 2001 |
| 6288072 |
Camptothecin .beta.-alanine esters with topoisomerase I inhibition |
Sep. 11, 2001 |
| 6284769 |
Nonpeptide kappa opioid receptor antagonists |
Sep. 4, 2001 |
| 6277829 |
Process for preparing of aqueous formulation for opthalmic use |
Aug. 21, 2001 |
|
|
|
